abstract |
The present invention relates to novel pyridone compounds or pharmaceutically acceptable salts thereof, a method for producing the same and a pharmaceutical composition containing the same for treating cancer. The compounds according to the present invention utilize the superior effects of the RUNX activity found in the HDAC inhibitor for inhibiting tumor cell growth, and are thus useful for treating cancer. |